Inventor profile of:

Sharon CLOAD

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

13

Last publication date:

2024-09-26

Top Assignees for applications by Sharon CLOAD

The entities that hold a legal rights for patent applications filed by inventor CLOAD Sharon:

Recent patent applications by CLOAD Sharon

Sharon CLOAD from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-26
US20240316161A1
Human necessities

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

#2 | 2019-10-10
US20190307855A1
Human necessities

Fibronectin based scaffold domain proteins that bind to myostatin

#3 | 2017-12-14
US20170354718A1
Human necessities

Fibronectin based scaffold domain proteins that bind to myostatin

#4 | 2017-03-30
US20170088602A1
Chemistry; metallurgy

Fibronectin based scaffold domain proteins that bind to myostatin

#5 | 2015-08-20
US20150231211A1
Human necessities

Fibronectin based scaffold domain proteins that bind to myostatin

#6 | 2015-03-12
US20150072919A1
Chemistry; metallurgy

Fibronectin based scaffold domain proteins that bind to myostatin

#7 | 2014-10-16
US20140309163A1
Chemistry; metallurgy

Fibronectin based scaffold domain proteins that bind to myostatin

#8 | 2014-04-17
US20140107020A1
Human necessities

Fibronectin based scaffold domain proteins that bind to myostatin

#9 | 2014-04-17
US20140105896A1
Chemistry; metallurgy

Fibronectin based scaffold domain proteins that bind to myostatin

#10 | 2010-05-13
US20100120024A1
Chemistry; metallurgy

Materials and methods for the generation of transcripts comprising modified nucleotides

#11 | 2009-03-19
US20090075342A1
Chemistry; metallurgy

Metabolic profile directed aptamer medicinal chemistry

#12 | 2009-01-15
US20090018093A1
Chemistry; metallurgy

Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics

#13 | 2007-01-11
US20070009907A1
Chemistry; metallurgy

Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics

InventorID:

727083 ⎘